Publications by authors named "Victoria E Wang"

9Publications

Evaluation of a National Comprehensive Cancer Network Guidelines-Based Decision Support Tool in Patients With Non-Small Cell Lung Cancer: A Nonrandomized Clinical Trial.

Authors:

Susan Y Wu Ann A Lazar Matthew A Gubens Collin M Blakely Alexander R Gottschalk David M Jablons Thierry M Jahan Victoria E H Wang Taylor L Dunbar Melisa L Wong Jason W Chan William Guthrie Jeff Belkora Sue S Yom

JAMA Netw Open 2020 09 1;3(9):e209750. Epub 2020 Sep 1.

Department of Radiation Oncology, University of California, San Francisco.

View Article and Find Full Text PDF

September 2020

Adaptive Resistance to Dual BRAF/MEK Inhibition in BRAF-Driven Tumors through Autocrine FGFR Pathway Activation.

Authors:

Victoria E Wang Jenny Y Xue Dennie T Frederick Yi Cao Eva Lin Catherine Wilson Anatoly Urisman David P Carbone Keith T Flaherty Rene Bernards Piro Lito Jeff Settleman Frank McCormick

Clin Cancer Res 2019 12 12;25(23):7202-7217. Epub 2019 Sep 12.

Helen Diller Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.

View Article and Find Full Text PDF

December 2019

Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer.

Nat Med 2019 01 26;25(1):111-118. Epub 2018 Nov 26.

Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.

View Article and Find Full Text PDF

January 2019

Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden.

Authors:

Victoria E Wang Anatoly Urisman Lee Albacker Siraj Ali Vincent Miller Rahul Aggarwal David Jablons

J Immunother Cancer 2017 09 19;5(1):75. Epub 2017 Sep 19.

Department of Surgery, University of California, San Francisco, USA.

View Article and Find Full Text PDF

September 2017

A Case of Metastatic Atypical Neuroendocrine Tumor with Translocation and Diffuse Brain Metastases.

Authors:

Victoria E Wang Lauren Young Siraj Ali Vincent A Miller Anatoly Urisman John Wolfe Trever G Bivona Bertil Damato Shannon Fogh Emily K Bergsland

Oncologist 2017 07 15;22(7):768-773. Epub 2017 May 15.

Department of Medicine, University of California, San Francisco, San Francisco, California, USA.

View Article and Find Full Text PDF

July 2017

New Strategies in Esophageal Carcinoma: Translational Insights from Signaling Pathways and Immune Checkpoints.

Authors:

Victoria E Wang Jennifer R Grandis Andrew H Ko

Clin Cancer Res 2016 Sep 1;22(17):4283-90. Epub 2016 Jul 1.

Division of Hematology and Oncology, University of California San Francisco, San Francisco, California.

View Article and Find Full Text PDF

September 2016

B cell development and immunoglobulin transcription in Oct-1-deficient mice.

Authors:

Victoria E H Wang Dean Tantin Jianzhu Chen Phillip A Sharp

Proc Natl Acad Sci U S A 2004 Feb 4;101(7):2005-10. Epub 2004 Feb 4.

Department of Biology and Center for Cancer Research and McGovern Institute, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139-4307, USA.

View Article and Find Full Text PDF

February 2004

Herpes simplex virus infections are arrested in Oct-1-deficient cells.

Authors:

Mauricio L Nogueira Victoria E H Wang Dean Tantin Phillip A Sharp Thomas M Kristie

Proc Natl Acad Sci U S A 2004 Feb 26;101(6):1473-8. Epub 2004 Jan 26.

Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 4-131, 4 Center Drive, Bethesda, MD 20892, USA.

View Article and Find Full Text PDF

February 2004

Embryonic lethality, decreased erythropoiesis, and defective octamer-dependent promoter activation in Oct-1-deficient mice.

Authors:

Victoria E H Wang Tara Schmidt Jianzhu Chen Phillip A Sharp Dean Tantin

Mol Cell Biol 2004 Feb;24(3):1022-32

Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA.

View Article and Find Full Text PDF

February 2004